Eisai: 18-Month, Pre-Specified Analysis Showing Consistent Reduction in Clinical Outcome Measures from a Lecanemab (BAN2401) Phase 2b Clinical Trial in Early Alzheimer's Disease
- Written by ACN Newswire - Press Releases
.
Sectorial ATO Tax Debt Disclosures Rise, Overall Business Credit Demand Flattens and High-Risk SME 'Credit Shopping' hits 8-month peak
Q1 2026 Equifax Business Market Pulse shows low-risk borrowers consolidate demand enquiries while sub-prime entities accelerate shopping activity ...
SME support in Federal Budget falls short of easing business pressures
“The Federal Budget delivered several measures aimed at supporting small businesses, including making the instant asset write-off permanent, exten...
Bunji dog treats to hit Ritchies shelves
Cooee Native Superfoods’ Bunji range of dog kibble and treats is rolling out across Ritchies Supermarkets now, with stock already on shelves in se...
Pre-Budget Expectations
“Australian corporates and SMBs are under pressure. Competition from global players is intensifying, margins are under strain, and technology adop...
“Time is running out to get Payday ready,” Brighter Super urges
Superannuation fund Brighter Super is encouraging business owners to prepare now for Payday Super, ahead of the new laws taking effect from 1 July...
PayNuts Unveils Expanded Integrated Solutions and Refreshed Brand to Support Australian SMEs
PayNuts, one of Australia’s fastest-growing payment service providers, has unveiled a refreshed brand identity and an expanded suite of integrated b...